Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28337932 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL6558553 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL11367859 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL21507727 | 1.00 | LMNA (0.68) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL11379791 | 0.97 | LMNA (0.65) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL29682364 | 0.97 | LMNA (0.65) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL538230 | 0.85 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL20928 | 0.85 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL8672325 | 0.85 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 | |
| SCHEMBL29662067 | 0.85 | LMNA (0.93) | LMNABLMPTPN1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3884032-B1 | APPARATUS AND METHOD FOR THE GROWTH OF PHOTOSYNTHETIC MICROORGANISMS AND THE BIOFIXATION OF CARBON DIOXIDE THROUGH A HIGH- EFFICIENCY OPTICAL DIFFUSER WITH VARIABLE SPECTRUM AND INTENSITY | EVERBLOOM SRL (IT) | 2023-08-02 | — | — | EP | claimed |
| US-8088395-B2 | Phytol derived immunoadjuvants and their use in vaccine formulations | INDIANA STATE UNIVERSITY (US) | 2012-01-03 | — | — | US | claimed |
| US-20060292163-A1 | PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS | INDIANA STATE UNIVERSITY | 2006-12-28 | — | — | US | claimed |
| US-20050158329-A1 | Novel phytol derived immunoadjuvants and their use in vaccine formulations | GHOSH SWAPAN K (US) | 2005-07-21 | — | — | US | claimed |
| WO-2025241022-A1 | PROCESS FOR OBTAINING AN EXTRACT WITH A HIGH LUTEIN CONTENT FROM MICROALGAE, EXTRACT WITH A HIGH LUTEIN CONTENT, AND USE OF THE OBTAINED EXTRACT | BOTICA COMERCIAL FARMACÊUTICA LTDA. (BR) | 2025-11-27 | — | — | WO | disclosed |
| US-20250257312-A1 | CONTAMINATION CONTROL WHEN GROWING GREEN ALGAE | HAMRICK EDWARD BRIAN (US) | 2025-08-14 | — | — | US | disclosed |
| CN-119736279-A | Antimicrobial endolysin polypeptides, compositions and formulations | 阿希坦有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-115135162-B | Method for increasing solubility of vegetable protein compositions | 睿普食品公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118339298-A | Nucleotide sequences for regulating transcription and methods of use | 巴斯夫农业种子解决方案美国有限责任公司 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024130271-A2 | CONTAMINATION CONTROL WHEN GROWING GREEN ALGAE | HAMRICK EDWARD BRIAN (US) | 2024-06-20 | — | — | WO | disclosed |
| CN-118056015-A | Biotechnological production method of aldehyde mixture | 西姆莱斯有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-111742054-B | Method for cascade processing of fresh algae | 沙比多斯公司 | 2024-04-23 | — | — | CN | disclosed |
| US-9920337-B2 | Methods for producing carbon-based chemicals by algal biomass processing | DIREVO INDUSTRIAL BIOTECHNOLOGY GMBH (DE) | 2018-03-20 | — | — | US | disclosed |
| US-20160355848-A1 | METHODS FOR PRODUCING CARBON-BASED CHEMICALS BY ALGAL BIOMASS PROCESSING | DIREVO INDUSTRIAL BIOTECHNOLOGY GMBH (DE) | 2016-12-08 | — | — | US | disclosed |
| EP-3022308-A1 | METHODS FOR PRODUCING CARBON-BASED CHEMICALS BY ALGAL BIOMASS PROCESSING | Direvo Industrial Biotechnology GmbH (DE) | 2016-05-25 | — | — | EP | disclosed |
| WO-2015007419-A1 | METHODS FOR PRODUCING CARBON-BASED CHEMICALS BY ALGAL BIOMASS PROCESSING | DIREVO INDUSTRIAL BIOTECHNOLOGY GMBH (DE) | 2015-01-22 | — | — | WO | disclosed |
| US-8088395-B2 | Phytol derived immunoadjuvants and their use in vaccine formulations | INDIANA STATE UNIVERSITY (US) | 2012-01-03 | — | — | US | disclosed |
| US-20060292163-A1 | PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS | INDIANA STATE UNIVERSITY | 2006-12-28 | — | — | US | disclosed |
| US-20050158329-A1 | Novel phytol derived immunoadjuvants and their use in vaccine formulations | GHOSH SWAPAN K (US) | 2005-07-21 | — | — | US | disclosed |
| US-4168271-A | Unsaturated vitamin E intermediates--dehydro and didehydro α-tocopherols | SCM CORPORATION (US) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050158329-A1 | Novel phytol derived immunoadjuvants and their use in vaccine formulations | CD47, TSG101, LY96 | LMNA 3976/4885BLM 1167/4885PTPN1 475/4885 |
| US-20060292163-A1 | PHYTOL DERIVED IMMUNOADJUVANTS AND THEIR USE IN VACCINE FORMULATIONS | CD47, LY96, CD4 | LMNA 3674/4885BLM 946/4885PTPN1 317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.